Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis: Double-blind Controlled Clinical Trial
Brief Summary: The adjunctive use of systemically administered antibiotics has been shown to provide a better clinical outcome, particularly in terms of probing depth (PD) reduction and attachment-level gain than SRP in subjects with Aggressive Periodontitis.

The overall objective of this study is to evaluate the clinical and microbiological efficacy of moxifloxacin as an adjunct to scaling and root planing versus scaling and root planing over placebo in the treatment of aggressive periodontitis.


Options:
A: Arm Label: clarithromycin group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clarithromycin, Other: One-stage full-mouth ultrasonic debridement (FMUD) | Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Other: One-stage full-mouth ultrasonic debridement (FMUD) | Intervention Type: DRUG; Name: Clarithromycin; Assigned to Arm(s): clarithromycin group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo group | Intervention Type: OTHER; Name: One-stage full-mouth ultrasonic debridement (FMUD); Assigned to Arm(s): clarithromycin group, placebo group
B: Arm Label: Scaling and root planing alone; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Scaling and root planing | Arm Label: SRP + Metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole | Arm Label: SRP + MET + Amoxicillin + Doxycycline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin, Drug: Doxycycline | Intervention Type: PROCEDURE; Name: Scaling and root planing; Assigned to Arm(s): Scaling and root planing alone | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): SRP + Metronidazole | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): SRP + MET + Amoxicillin + Doxycycline | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): SRP + MET + Amoxicillin + Doxycycline
C: Arm Label: YH14642 A-I; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-II; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-III; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: Active Comparator B; Type: ACTIVE_COMPARATOR; Interventions: Drug: INSADOL[Zea mays L. extract] 35mg Tab | Arm Label: Active Comparator C; Type: ACTIVE_COMPARATOR; Interventions: Drug: DENTISTA[Doxycycline hyclate] 20mg Cap | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-I | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-II | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-III | Intervention Type: DRUG; Name: INSADOL[Zea mays L. extract] 35mg Tab; Assigned to Arm(s): Active Comparator B | Intervention Type: DRUG; Name: DENTISTA[Doxycycline hyclate] 20mg Cap; Assigned to Arm(s): Active Comparator C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: scaling and root planing; Type: PLACEBO_COMPARATOR; Interventions: Other: scaling and root planing | Arm Label: scaling and systemic moxifloxacin; Type: EXPERIMENTAL; Interventions: Other: scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and systemic moxifloxacin; Assigned to Arm(s): scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and root planing; Assigned to Arm(s): scaling and root planing

Answer: D